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death. Mitochondrial diseases are characterized by a marked anatomical and cellular specificity. 23 However, the molecular determinants for this susceptibility are currently unknown, hindering the 24 efforts to find an effective treatment. Due to the complex crosstalk between mitochondria and their 25 supporting cell, strategies to assess the underlying alterations in affected cell types in the context of 26 mitochondrial dysfunction are critical. Here, we developed a novel virus-based tool, the AAV-27 mitoTag viral vector, to isolate mitochondria from genetically-defined cell types. Administration of 28 the AAV-mitoTag in the vestibular neurons of a mouse model of Leigh Syndrome lacking the 29 complex I subunit Ndufs4 allowed us to assess the proteome and acetylome of susceptible neurons in 30 a well characterized model recapitulating the human disease. Our results show a marked reduction of 31 complex-I N-module subunit abundance and an increase in the levels of the assembly factor 32 NDUFA2. Transiently-associated non-mitochondrial proteins such as PKCδ, and the complement 33 subcomponent C1Q were also increased in Ndufs4-deficient mitochondria. Furthermore, lack of 34
Ndufs4 induced pyruvate dehydrogenase (PDH) subunit hyperacetylation, leading to decreased PDH 35 activity. We provide novel insight on the pathways involved in mitochondrial disease, which could 36 underlie potential therapeutic approaches for these pathologies.
Introduction 38
Severe alterations of the mitochondrial machinery involved in energy generation lead to a group of 39 progressive and usually fatal pathologies collectively known as primary mitochondrial disease (MD), 40 affecting 1:5000 births (Schaefer et al., 2004) . Currently, there is no cure and the treatments available 41 are mostly ineffective (Schon et al., 2010) . MD predominantly affects high energy-requiring organs 42 such as the brain (Vafai and Mootha, 2012) . Indeed, neurological damage plays a prominent role in 43 MD pathology and lethality (DiMauro and Schon, 2008) . However, not all neuronal populations are 44 equally vulnerable to MD, but rather show a striking anatomical and cellular specificity (Dubinsky, 45 2009 ). Recent reports have evidenced the remarkable regional heterogeneity in mitochondrial protein 46 composition in the brain, which may account for the cell type specificity of MD (Pagliarini et al., 47 2008) 48
Humans harboring mutations in NDUFS4, a subunit of the mitochondrial complex I involved in the 49 assembly and stability of the complex ( Breuer et al., 2013) . As observed in LS patients, NDUFS4 deficiency in mice leads to 55 prominent bilateral lesions in the dorsal brainstem, more specifically in the vestibular nucleus (VN). 56 Conditional NDUFS4 ablation restricted to the VN causes a pathology similar to global Ndufs4KO 57 mice. Conversely, viral-mediated re-expression of Ndufs4 in the VN is sufficient to ameliorate the 58 pathology and to extend the lifespan of Ndufs4KO mice (Quintana et al., 2012a ). In addition, 59
NDUFS4 deficiency reveals a cell type-specific susceptibility to the disease. NDUFS4 ablation in 60 glutamatergic neurons (Vglut2-expressing) recapitulates most of the phenotype present in the global 61 NDUFS4-deficient mice (Bolea et al., 2019) , thus warranting further study of glutamatergic neurons 62 in the VN. 63
Here, we have developed and implemented a novel viral vector approach (AAV-mitoTag) to purify 64 cell type-specific mitochondria in a fast and minimally-disruptive manner from glutamatergic
Mouse genetics 81
Slc17a6 Cre (BAC-Vglut2::Cre) mice were generated by Ole Kiehn (Borgius et al., 2010) . Ndufs4 lox/lox 82 and Ndufs4 Δ/+ were previously generated by our group (Kruse et al., 2008; Quintana et al., 2010) . 83 Mice with conditional deletion of Ndufs4 in Vglut2-expressing glutamatergic neurons (Slc17a6 Cre , 84
Ndufs4 Δ/lox or Vglut2:Ndufs4cKO) were generated by crossing mice with one Ndufs4 allele deleted 85 and expressing a codon-improved Cre recombinase (iCre) under the Slc17a6 promoter (Slc17a6 Cre , 86
Ndufs4 Δ/+ ) to mice with two floxed Ndufs4 alleles (Ndufs4 lox/lox ). Littermate controls were Slc17a6 Cre , 87
Ndufs4 lox/+ (Vglut2:Ndufs4cCT 
MitoTag Adeno-Associated viral vector (AAV) generation 153
We generated an adeno-associated virus (AAV) that would initiate Cre-inducible mitoTag expression 154 using a double floxed inverted open reading frame (DIO) approach. An NheI/AscI fragment 155 containing a construct coding for the mouse Tomm20 gene fused to three hemagglutinin (HA) 156 sequences (Tomm20·3HA) was cloned into a NheI/AscI-digested pAAV-EF1a-DIO-WPRE-hGH 157 polyA plasmid to obtain a pAAV1-EF1a-DIO-Tomm20·3HA-WPRE-hGH polyA construct (AAV-158 mitoTag). An AAV (AAV1 serotype) vector was produced and CsCl-gradient purified as described 159
previously (Quintana et al., 2012b) . The TOM20-HA fusion protein was generated by mutation of 160
Tomm20 stop codon to glutamic acid (E) and phenylalanine (F). 161
162

AAV-mitoTag delivery 163
Mice (n=28, 37.4±7 days, 22.1±3.2 g) were anaesthetized with isoflurane (5.0 % induction, 1.5-0.7 % 164 maintenance) and placed in a stereotaxic frame (Kopf Instruments). Ketoprofen analgesic solution 165
(5 mg/kg s.c; Sanofi-aventis) and ocular protective gel (Viscotears®) were applied before stereotaxic 166 procedure. Mice received intracranial AAV injections into the vestibular nucleus (VN) at the 167 following coordinates: AP −0.6, ML ± 0.125, DV −0.39 mm from the Bregma, using the correction 168 factor (Bregma − Lambda/4.21). A total of 1.0 μL of AAV-mitoTag vector (0.7 × 10 12 viral 169 genomes/mL; 0.5 μL per side) was injected into each hemisphere at a rate of 0.25 μL/min using a 5 170 μL Hamilton syringe with a 32G blunt needle. Following injection, the needle was kept in place for 4 171 minutes post-delivery to allow proper viral vector diffusion and, subsequently, removed at 1 172 mm/min. 173 174
Isolation of mitochondria by immunoaffinity purification 175
For HEK293T cells, 200,000 cells/mL were transduced with AAV-mitoTag and a viral vector 176
expressing Cre recombinase (AAV-Pkg-Cre; UNC Vector Core) or left untransduced for 4 days prior 177
to lysis in mitochondria isolation kit lysis buffer (1x10 7 cells/mL; Miltenyi Biotec) with protease 178 inhibitors (Sigma-Aldrich) and homogenized by passing the lysate 25 times through a 1 mL syringe 179 with a 25G needle. Homogenized lysates were next centrifuged at 700 x g for 10 min at 4ºC, and 180 supernatants collected and incubated with anti-HA or anti-TOM22 microbeads (Miltenyi Biotec) 181
according to manufacturer's directions. Mitochondria from glutamatergic cells in the vestibular 182 nucleus (VN) were isolated from freshly collected mouse brain tissue. Tissue homogenates were 183 prepared using the Mitochondria Extraction Kit, tissue (Miltenyi Biotec) according to manufacturer's 184 instructions. Briefly, following decapitation, brains were weighted, and vestibular nuclei dissected 185
according to the Paxinos mouse brain atlas and digested with extraction buffer for 30 min at 4°C. 186
After centrifugation at 300 × g for 5 min at 4°C, pellets were resuspended in Solution 2 supplemented 187 with EDTA-free protease inhibitor cocktail (Roche Diagnostics), and deacetylase inhibitors (10 mM 188 nicotinamide, 10 μM TSA and 10 mM sodium butyrate). Digested tissue was homogenized using a 189 glass dounce homogenizer. Homogenates were centrifuged at 1,000 × g for 5 min at 4ºC. 190
Subsequently, supernatants containing mitochondria were further purified as directed in the 191
Mitochondria Isolation Kit (Miltenyi Biotec). For magnetic labeling and isolation, supernatants 192 diluted in Separation Buffer were incubated with 50 μL of anti-HA Microbeads on a shaker (60 rpm) 193
for 1 h at 4 ºC. Subsequently, LS columns (Miltenyi Biotec) were placed in a magnetic 194
QuadroMACS™ Separator (Miltenyi Biotec) and equilibrated with 3 mL Separation Buffer (Miltenyi 195 Biotec). Microbead-coated mitochondria were applied onto the LS column, followed by three 3-mL 196
washing steps with Separation Buffer. Columns were removed from the separator and mitochondria 197 gently flushed out in 1.5 mL of Separation Buffer with a plunger. Mitochondria were pelleted by 198 centrifugation for 2 minutes at 12,000 x g and washed twice with Storage Buffer. Two 199 immunoprecipitations (from 4-5 mice) were pooled for proteomic analysis. 200 201
Isolation of mitochondria by double centrifugation 202
Mitochondria were isolated by differential centrifugation using protocols previously described 203 (Brown et al., 2004; Pagliarini et al., 2008) . Briefly, following decapitation, vestibular nuclei were 204 dissected according to the Paxinos mouse brain atlas and homogenized using a glass dounce 205 homogenizer containing MAS buffer (70 mM sucrose, 220 mM mannitol, 10 mM KH2PO4, 5 mM 206
MgCl2, 1 mM EGTA, 2 mM HEPES-KOH, pH 7.2). Homogenates were centrifuged at 900 × g for 10 207 min at 4°C. Supernatants were further centrifuged at 9,000 × g for 10 min at 4°C. Resulting 208 supernatants were discarded and pellets containing mitochondria were resuspended in MAS buffer. 209
Protein concentration was determined using the BCA protein assay (Thermo Fisher Sci.) according to 210 the manufacturer's instructions. 211 212 213 PDH enzyme activity 215 PDH activity was measured in VN homogenates by using the Pyruvate Dehydrogenase (PDH) 216
Enzyme Activity Microplate Assay Kit (Abcam) according to manufacturer's instructions. Briefly, 217 mitochondria isolated by double centrifugation (50 μg) were loaded into the wells of a 96-well plate 218 that was specific for PDH activity assay. PDH enzyme was immunocaptured by the monoclonal 219 antibodies coated on the wall of each well. The enzymatic activity of PDH was determined based on 220 the production of NADH coupled to a reporter dye whose formation is monitored by measuring the 221 increase in absorbance at 450 nm on a Varioskan LUX plate reader (Thermo Fisher Sci.). 222
223
Measurement of respiration in isolated mitochondria 224
Oxygen consumption rate (OCR) was measured in MAS buffer supplemented with 0.5 % (w/v) fatty 225 acid-free BSA, using a Seahorse XFp Extracellular Flux Analyzer (Agilent Technologies, Inc). 226
Freshly isolated mitochondria (5-20 μg of protein) obtained by double centrifugation were plated in 227 each well of an XFp plate in 25 μL of MAS-BSA Buffer. To attach mitochondria, the plate was 228 centrifuged at 2,000 x g at 4°C for 20 min and then 155 μL of MAS-BSA buffer containing 10 mM 229 pyruvate/5 mM malate, 100 μM palmitoyl-L carnitine/5 mM malate, or 20 mM succinate/4 µM 230 rotenone was added to each well. First, basal measurements of oxygen consumption rate (state 2) 231
were obtained. Next, ADP (5 mM) was injected (state 3), followed by sequential injections of 232 oligomycin (2 µM, state 4o), FCCP (5 µM, state 3u) and antimycin A/rotenone (2.5 µM and 2 µM 233 respectively) to disrupt mitochondrial respiration. Together, this injection series allowed for the 234 determination of ADP-uncoupled respiration (ADP), proton leak (oligomycin), maximal respiration 235 (FCCP) and non-mitochondrial residual oxygen consumption (antimycin A/rotenone). 236 237
Protein extraction and digestion 238
Mitochondria from glutamatergic neurons in the vestibular nucleus were immunocaptured as 239 described above. These mitochondria were then suspended in lysis buffer (4% (w/v) SDS, 100 mM 240
Tris-HCl, pH 7.6, 0.1 M DTT) and incubated at 95ºC for 5 min. Protein extracts were quantified 241 using RC-DC TM Protein Assay (Bio-Rad). Three biological replicates from Vglut2:Ndufs4cCT and 242
Vglut2:Ndufs4cKO mice mitochondria were processed. Protein was digested with sequencing grade 243 modified trypsin (Promega) using the FASP (Filter Aided Sample Preparation) digestion 244
protocol ( extract was washed three times with 100 µL of UA buffer and three times with 100 µL of 200 mM 250 triethylammonium bicarbonate (TEAB). Trypsin digestion was performed at 37°C for 18 h using an 251 enzyme-to-protein ratio of 5:100. Tryptic peptides were eluted by the addition of 3 × 100 μL of 200 252 mM TEAB followed by a centrifugation at 14,000 × g for 15 min at 13 °C. 253 254
Peptide labeling by isobaric tandem mass tag 255
Each tryptic peptide mixture obtained from 150 μg of protein extract was isotopically labeled with 256 the corresponding TMT6plex reagent (Thermo Fisher Sci.) based on the standard procedure. TMT-257 labeled peptide mixtures were combined in a low-bind 1.5 mL Eppendorf tube, evaporated, and 258 desalted using a C18 SPE cartridge (Agilent Technologies). The SPE eluates were evaporated and 259 resuspended in 50 mM MOPS pH 7.2, 10 mM Na2HPO4, 50 mM NaCl. 260 261
Acetylated Peptide Enrichment 262
The TMT-labeled peptide mixtures (900 μg) were enriched for acetylated peptides by 263 immunoaffinity purification using an anti-acetyl lysine antibody following the PTMScan® Pilot 264
Acetyl-Lysine Motif (Ac-K) protocol (Cell Signaling Technologies Data are shown as the mean ± SEM. GraphPad Prism v5.0 software was used for statistical analyses. 306 Appropriate tests were selected depending on the experimental design as stated in the figure legends. 307
Statistical significance, when reached (P <0.05 was considered significant), is stated in the figure  308 legends. 309 310 3
Results 311
Generation and validation of the AAV-mitoTag viral vector 312
To allow the isolation of the mitochondria from susceptible neuronal cell types, a Cre-dependent 313 mitoTag adenoassociated viral vector (AAV-mitoTag) was generated by inserting the cDNA of an 314
HA protein showed the expected molecular weight. Immunofluorescence analysis for HA in cells 320
transfected with the mitoTag viral vector construct and transduced with viral vector particles 321
expressing Cre recombinase showed a localization of the fusion protein consistent with incorporation 322 into mitochondria (Fig. 1C) . To test whether whole mitochondria isolation from Cre-expressing cells 323 could be accomplished by an immunocapture method, lysates from HEK293T/17 cells transduced 324
with the AAV-mitoTag viral vector (AAV-DIO-Tomm20·HA) along with a Cre recombinase-325 expressing viral vector (AAV-Cre) were used to immunoprecipitate HA-tagged mitochondria with 326 anti-HA coated magnetic microbeads (Fig. 1D ). Anti-TOM22 coated magnetic microbeads were also 327 used as control to immunoprecipitate unlabeled mitochondria from non-transduced cells. Western 328 blot analysis of the immunoprecipitates showed specific immunoisolation of mitochondria without 329 contamination from cytosolic proteins. 330
Cell type-specific isolation of mitochondria from glutamatergic neurons in the VN 331
Glutamatergic neurons (Vglut2-expressing) in the VN have been proven susceptible to complex I 332 deficiency (Bolea et al., 2019) . To define the factors driving this specific susceptibility, we first 333 confirmed the feasibility of the AAV-mitoTag approach for the isolation of mitochondria from this 334 genetically defined neuronal population in vivo. To show expression of the mitoTag in mitochondria 335 from the cell type of interest, AAV-mitoTag viral vector was injected bilaterally into the VN of 336
Slc17a6 Cre (Vglut2 Cre ) mice. Subsequently, brain sections containing the area were analyzed by 337 immunofluorescence using anti-HA antibodies ( Fig. 2A) . HA staining was restricted to specific cells 338 in the VN, and double-labeling analysis using anti-HA and anti-TOM20 antibodies confirmed the 339 mitochondrial localization of the mitoTag (Fig. 2B ). Immunocapture of mitochondria from Vglut2-340 expressing cells was accomplished from lysates of pooled vestibular nuclei using Anti-HA coated 341 magnetic microbeads (Fig. 2C) . Western blot analysis of whole lysates (input of the 342 immunoprecipitation) and immunoprecipitates showed specific enrichment for mitochondrial 343 markers such as the mitochondrial porin VDAC1 or the translocase of the outer mitochondrial 344 membrane TOM20. In contrast, cytosolic markers such as the cytoskeleton protein beta-Actin or 345 endoplamatic reticulum (ER) markers such as calreticulin, appeared depleted in the IP, confirming 346 mitochondrial enrichment in vivo with the mitoTag approach (Fig. 2D ). Electron microscopy (EM) 347 analysis of the immunoprecipitates from VN lysates of Vglut2 Cre mice injected with the mitoTag viral 348 vector confirmed binding of the anti-HA magnetic microbeads to the outer membrane of whole 349 mitochondria ( Fig. 2E) . 350 showed significantly reduced levels in NDUFS4-deficient mitochondria, except for the assembly 371 factor NDUFAF2, which showed increased abundance in these mitochondrial preparations ( Fig. 3A-372 B). Constituents of the NADH dehydrogenase module (N-module: NDUFA2, NDUFA12, NDUFV1, 373 NDUFV2, NDUFV3, NDUFS1, NDUFS6 and NDUFS4) were the most significantly decreased 374 proteins in these mitochondria (Fig. 3B ). Constituents of the Q-module, which is located adjacent to 375 N-module, and specific subunits of the P-Module, were also reduced in Vglut2:Ndufs4CKO VN 376 mitochondria (Fig. 3B) . Proteins with increased abundance in these mitochondria included the A, B 377 and C-chain polypeptides of the complement subcomponent C1q (C1QA, C1QB, C1QC), which are 378 known to bind to the mitochondrial protein gC1qR (globular head C1q receptor or C1QBP) to 379 modulate mitochondrial metabolism (Ling et al., 2018), and protein kinase C delta (PKC), a 380 member of the protein kinase C family of serine-and threonine-specific protein kinases that 381 translocates to mitochondria upon different stimuli (Majumder et al., 2001) . The beta and gamma1 382 subunits of the glycogenolytic phosphorylase kinase complex (PHKB and PHKG1) also appeared 383 increased. Functional enrichment analysis for overrepresented biological processes ( Fig. 3C ) and 384 pathways ( Fig. 3D ) confirmed complement-mediated signaling and glycogen metabolism as the most 385 enriched protein sets (terms) in the analysis of the proteins with increased abundance in mitochondria 386 from the VN of Vglut2:Ndufs4cKO mice. Analysis of underrepresented proteins resulted in highly 387 significant categories confirming a role in mitochondrial organization, and more specifically in 388 respiratory electron transport and complex I biogenesis for the proteins that showed reduced presence 389 in NDUFS4-deficient mitochondria. 390
Identification and quantitation of the global and acetyl-proteome in mitochondria from
To explore the functional relevance of the proteomic alterations observed in Vglut2:Ndufs4cKO 391 mice, we conducted bioenergetics analysis on mitochondria preparations from the VN. Mitochondrial 392 oxygen consumption rate (OCR) was assessed by using a Seahorse XF24 extracellular flux analyzer 393 (Fig. 3E ). Mitochondria were first incubated with pyruvate and malate as respiratory complex I 394 substrates (state 2). Then, ADP was injected to induce phosphorylation (state 3), followed by 395 oligomycin to inhibit the ATP synthase (state 4) and the chemical uncoupler FCCP to induce 396 maximal respiration (state 3u). VN mitochondria from Vglut2:Ndufs4cKO mice exhibited a profound 397 decrease in the OCR (state 2, 3 and 3u) compared to Vglut2:Ndufs4cCT mice. A more detailed 398 analysis of VN mitochondria respiration (Fig. 3F ) revealed significantly reduced spare capacity, 399 proton leak and ATP-linked respiration in Vglut2:Ndufs4cKO compared to control mice. Finally, 400
whether the decrease VN mitochondria bioenergetics was complex-I mediated was investigated. To 401 that end, we used saturating concentrations of specific substrates for complex I (pyruvate/malate), 402
complex II (succinate/rotenone) and -oxidation (palmitoyl-carnitine/malate) ( Fig. 3F-G) . OCR 403 results revealed that state 3 (ADP-induced) and state 3u (FCCP-induced) respirations were similar 404 between Vglut2:Ndufs4cKO and control mice for complex II and -oxidation substrates. 405
Collectively, these data show a selective complex I-mediated dysfunction in mitochondria from the 406 VN of Vglut2:Ndufs4cKO mice. 407 408
Hyperacetylation of PDH subunits in VN neurons of Vglut2:Ndufs4cKO mice 409
Mitochondrial complex I deficiency has been shown to lead to protein hyperacetylation in the heart 410 (Karamanlidis et al., 2013) . Hence, we next sought to assess changes in protein acetylation due to 411 NDUFS4 deficiency in mitochondria from glutamatergic neurons in the VN. Acetylated proteins and 412 their modification sites were identified after peptide labeling and affinity enrichment of lysine-413 acetylated (Kac) peptides by high-resolution LC-MSn in mitoTag preparations from 414
Vglut2:Ndufs4cKO and Vglut2:Ndufs4cCT mice ( Figure 4A ). A total of 3,445 spectra corresponding 415 to 2,364 nonredundant peptides (928 proteins) were identified through database search (1% FDR). 416
From these, 798 lysine acetylated peptides in 368 protein groups were accurately quantified. A total 417 of 94 differentially acetylated peptides were identified in mitoTag preparations from the VN of 418
Vglut2:Ndufs4cKO mice when compared to controls (p≤ 0.05). Functional protein association 419 network analysis of differentially acetylated proteins using STRING (Fig. 4B ) showed that these fit 420 into different GO biological process nodes, being oxidation-reduction process, ATP metabolic 421 process, mitochondrial respiratory chain complex I assembly and pyruvate metabolic process the 422 most significantly enriched biological process categories. Among these proteins, 55 peptides 423 displayed decreased lysine acetylation, and many (n=20) matched to complex I subunits, including 424 NDUFA2, NDUFA5, NDUFA9, NDUFA10, NDUFA12, NDUFAB1, NDUFB3, NDUFB4, 425 NDUFB5, NDUFB6, NDUFB9, NDUFS1 and NDUFV1. Normalization to the total protein 426 abundance confirmed these data. On the other hand, 39 peptides showed increased lysine acetylation, 427 7 of them corresponding to PDHA1, a subunit that plays a key role in the function of the pyruvate 428 dehydrogenase (PDH) complex. LC-MSn analysis identified 9 sites of lysine acetylation out of all 23 429 lysine residues on the PDHA1 enzyme ( Figure 4C-D) . An annotated spectrum of regulated sites of 430 acetylation is provided in Fig. 4C . Among them, 5 sites (K63, K77, K83, K321 and K385) showed 431 increased acetylation in NDUFS4-deficient mitochondria (fold-change> 1.2; p≤ 0.05) (Fig. 4E ). To 432 correlate this increased acetylation in specific residues of PDHA1 with changes in the activity of the 433 enzyme, we next assessed mitochondrial preparations from Vglut2:Ndufs4cKO and control mice for 434 PDH activity. Mitochondrial preparations from the VN of Vglut2:Ndufs4cKO mice showed reduced 435 PDH activity when compared to controls (Fig. 4F ). No significant changes were observed in the 436 abundance of PDH subunits (PDHA1, PDHB, DLAT, DLD, PDHX) in mitoTag-isolated 437 mitochondria from the VN of Vglut2:Ndufs4cKO mice when compared to controls (Fig. 4G) . 438 439 4
Discussion 440
The mechanisms conferring neuronal vulnerability to MD are currently unknown. However, these 441
have been proven to be highly cell type-specific. Here, we have developed a tool that allows rapid, 442 viral vector-based isolation of mitochondria with cell type specificity and in a spatiotemporally 443 restricted fashion, with the overarching goal of identifying the underlying cellular mechanisms 444 driving neuronal susceptibility to mitochondrial dysfunction. Recently, the urgent need to develop 445 approaches to assess mitochondrial (dys)function in susceptible cell types has led to the generation of 446 different genetic tools to isolate mitochondria with cell-type specificity (Bayraktar et al., 2019; 447 Fecher et al., 2019). These are based on mouse lines that conditionally express, in a Cre recombinase-448 dependent manner, a tag (GFP or 3XHA-EGFP) that is targeted to the outer mitochondrial membrane 449
to enable immunocapture of mitochondria from specific cell types. However, these approaches are 450 limited by the possibility of unexpected transient expression of Cre recombinase during development 451
in defined cell types (Song and Palmiter, 2018) . A significant number of Cre-driver cell lines rely on 452 temporally dynamic promoters that may be transiently active during development, leading to off-453 target recombination events that compromise the cell type specificity and significantly limiting the 454 application of these tools (Lam et al., 2011; Sanz et al., 2015) . Cre-dependent viral vector-based 455 approaches such as our mitoTag assay allow delivery of the transgene into the adult brain, therefore 456 overcoming this important limitation. In addition, viral vector-based approaches avoid complex and 457 time-consuming breeding strategies and enable temporal and regional control, therefore allowing 458 rapid and anatomically restricted mitoTag assays. 459
Our proteomics data shows that NDUFS4 deficiency leads to mitochondria depleted of most of the 460 subunits of the respiratory chain NADH dehydrogenase (complex I; CI). Complex I (CI; NADH: 461 ubiquinone oxidoreductase; EC 1.6.5.3) is essential for oxidative energy metabolism as it contributes 462 to the generation of the proton motive force needed for ATP synthesis (Hirst, 2013) . This complex 463 has a boot-shaped structure with a hydrophilic matrix arm and a hydrophobic membrane arm that is 464 embedded in the inner mitochondrial membrane. These arms are subdivided into three structurally 465 and functionally defined modules: the N-module (involved in NADH binding and oxidation; where 466 NDUFS4 is located), the Q-module (for transfer of electrons along Fe-S clusters to ubiquinone), and 467 the P-module (mediating proton pumping) ( Our analysis of mitochondria also revealed mitochondrial association of characterized non-479 mitochondrial proteins upon NDUFS4 deficiency, which would remain unnoticed if a global analysis 480 of the cellular proteome is performed. Vglut2:Ndufs4cKO mitochondria showed increased abundance of the three different polypeptide chains that compose the complement subcomponent C1q. C1q has 482 been shown to be present within the cell (Ten et al., 2010; Ghebrehiwet et al., 2012) , and one of the 483 receptors for C1q, the globular head C1q receptor (gC1qR), is a mitochondrial cell-surface protein 484 known to modulate metabolism through association with C1q (Dedio et al., 1998; Kolev and 485 Kemper, 2017). In this regard, an effect on spare respiratory capacity and oxygen consumption has 486 been shown by gC1qR-bound C1q, which is known to enhance nuclear transcription of mitochondrial 487 biogenesis genes (Ling et al., 2018) . Association of C1q with NDUFS4-deficient mitochondria may 488 be a mechanism of the cell to promote mitochondrial biogenesis to overcome mitochondrial 489 dysfunction. Conversely, C1q has also been shown to mediate mitochondrial ROS production by 490 cortical neurons in neonatal hypoxic-ischemic brain injury and that C1q-deficient brain mitochondria 491 present preserved activity of the respiratory chain (Ten et al., 2010), suggesting tissue-and likely cell 492 type-specific mitochondrial roles of complement factors. Therefore, the role of C1q association to 493 NDUFS4-deficient mitochondria warrants further research. 494 Furthermore, our direct proteomics approach has detected increased abundance of PKC in mitoTag 495 preparations from Vglut2:Ndufs4cKO mice, suggesting mitochondrial translocation of this kinase in 496 NDUFS4-deficient vulnerable neuronal populations. In this regard, PKC has been shown to 497 translocate to mitochondria upon different stressors and in different neurodegenerative pathologies, 498
including with a decreased NAD + /NADH ratio, inhibiting the activity of the mitochondrial sirtuin deacetylase 507 SIRT3, and leading to protein hyperacetylation (Karamanlidis et al., 2013) . However, the effect of 508 NDUFS4-deficiency on the mitochondrial acetylome of neurons susceptible to MD was unknown. 509
Analysis of the mitochondrial acetylome in mitoTag preparations greatly reduces the complexity of 510 the sample by avoiding the interference of heavily acetylated cytosolic and nuclear proteins. This 511 results in increased identification of acetylated peptides corresponding to mitochondrial proteins. We 512 report increased abundance of acetylated peptides corresponding to PDHA1 in NDUFS4-deficient 513 mitochondria. PDHA1 is the E1 alpha 1 subunit containing the E1 active site of the pyruvate 514 dehydrogenase (PDH) complex, involved in transforming pyruvate into acetyl-CoA that is 515 subsequently used by both the citric acid cycle and oxidative phosphorylation to generate ATP. 516
Increased acetylation at specific PDHA1 sites anticipated reduced activity of the enzyme since 517 acetylation is typically reported to inhibit the catalytic activity of mitochondrial enzymes (Ghanta et  518 al., 2013). More specifically, it has been described that acetylation of PDHA1 at K83 and K321 519 reduce the activity of the enzyme. Noteworthy, both K83 and K321 residues are SIRT3 substrates 520 (Fan et To date, the marked heterogeneity in mitochondrial composition and function has limited our 528 understanding of the underlying molecular determinants of the neuronal susceptibility to 529 mitochondrial dysfunction. Therefore, it is paramount to study mitochondrial function in a 530 genetically-defined manner to unravel the pathogenic mechanisms of mitochondrial disease. Here, by 531
combining mouse genetics and cell type-specific mitochondrial isolation, we have assessed the 532 mitochondrial proteome of a neuronal population shown to be highly susceptible to mitochondrial 533 dysfunction in a well-established mouse model of mitochondrial disease. Our results underscore the 534 marked consequences of CI-deficiency in the proteome of affected neurons, identifying the metabolic 535 consequences of such alterations. Furthermore, we have identified a potential role for PDH, the 536 complement factor C1q, and PKCδ in the pathology, paving the way for future studies of the 537 therapeutic potential of modulating these pathways in the quest for effective treatments of 538 mitochondrial disease. 539
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